Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
TRVI

Updated 10/6/2026, 8:56 AM ET.

TRVI

Trevi Therapeutics, Inc.

Sale$595,806

Heffernan Michael Thomas

Director

39,473 shat $15.09Filed Sep 17, 4:55 PM ET
Filing

Read from public SEC filings. Not financial advice.